TickerFactsScreenerDevelopers

Sonoma Pharmaceuticals, Inc. (SNOA) — Cash & Equivalents

Annual figures by fiscal year, from SEC filings.

2010: $6.26M2011: $4.37M2012: $3.35M2013: $7.90M2014: $5.48M2015: $6.14M2016: $7.47M2017: $17.46M2018: $10.07M2019: $3.69M2020: $3.69M2021: $4.22M2022: $7.40M2023: $3.82M2024: $3.13M2025: $5.37M2026: $2.40M$2.40M
2010Cash & Equivalents (USD)2026
Fiscal YearCash & EquivalentsChange YoY
2026$2.40M-55.4%
2025$5.37M+71.8%
2024$3.13M-18.1%
2023$3.82M-48.4%
2022$7.40M+75.3%
2021$4.22M+14.3%
2020$3.69M+0.1%
2019$3.69M-63.4%
2018$10.07M-42.4%
2017$17.46M+133.8%
2016$7.47M+21.7%
2015$6.14M+12.0%
2014$5.48M-30.6%
2013$7.90M+135.8%
2012$3.35M-23.3%
2011$4.37M-30.2%
2010$6.26M—